Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status
Howard Yeh(Hospital de Santa Maria), James R. Berenson(Oncotherapeutics (United States)), Steven J. Manyak(Institute for Myeloma & Bone Cancer Research), Gabriel N. Waterman(Institute for Myeloma & Bone Cancer Research), Benjamin Bonavida(University of California, Los Angeles), Melinda S. Gordon(Institute for Myeloma & Bone Cancer Research), Mingjie Li(Shenyang Pharmaceutical University), Hee Jin Lee(Ulsan College), Haiming Chen(Guangzhou University of Chinese Medicine), Richard A. Campbell(Institute for Myeloma & Bone Cancer Research), Jonathan Ma(Virginia Commonwealth University), Cathy Wang(Institute for Myeloma & Bone Cancer Research), Regina A. Swift(Institute for Myeloma & Bone Cancer Research)
Cited by 16
Related Papers
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention
|Journal of Experimental & Clinical Cancer Research|2014|450
Trop2 and its overexpression in cancers: regulation and clinical/ therapeutic implications
|Genes & Cancer|2014|386
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
|Journal of Clinical Oncology|2000|383